Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
Khoo AL, Zhao YJ, Teng M, Ying D, Jin J, Chee YL, Poon LM, Lim SE, Koh LP, Chng WJ, Lim BP, Hsu LY, Chai LYA.
Khoo AL, et al. Among authors: teng m.
Int J Antimicrob Agents. 2018 Sep;52(3):350-357. doi: 10.1016/j.ijantimicag.2018.04.017. Epub 2018 May 9.
Int J Antimicrob Agents. 2018.
PMID: 29751120